Young adult with cannabis use, COVID history, and severe psychosis made a complete recovery

A young adult with cannabis use, vaping, prior COVID-19, a pineal cyst, and extreme blood pressure elevation developed severe psychosis but achieved complete recovery on a first-generation antipsychotic and mood stabilizer.

Siembida, Jagoda et al.·Cureus·2022·Preliminary EvidenceCase Report
RTHC-04219Case ReportPreliminary Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

A young adult presenting with multiple potential contributors to psychosis (cannabis use disorder, excessive vaping, COVID-19 history, pineal cyst, extreme hypertension) achieved complete recovery on haloperidol and a mood stabilizer, highlighting the diagnostic complexity of first-break psychosis.

Key Numbers

One patient with typical onset age for psychotic symptoms. Multiple potential contributing factors identified. Complete recovery achieved on first-generation antipsychotic plus mood stabilizer.

How They Did This

Single case report with clinical documentation of symptoms, diagnostic workup, treatment course, and outcome.

Why This Research Matters

First-break psychosis in young adults is often oversimplified as either substance-induced or schizophrenia-spectrum. This case shows how multiple factors can converge, making diagnosis uncertain but complete recovery still possible.

The Bigger Picture

With cannabis use, vaping, and COVID-19 all increasingly common in young adults, clinicians may encounter more cases where multiple potential causes of psychosis overlap, requiring careful diagnostic reasoning.

What This Study Doesn't Tell Us

Single case report cannot establish causation or generalizability. The relative contribution of each factor (cannabis, COVID, pineal cyst, hypertension) remains unknown.

Questions This Raises

  • ?How often does complete recovery occur in first-break psychosis with multiple contributing factors?
  • ?Did COVID-19 contribute to this psychotic episode?
  • ?Would this patient have developed psychosis without cannabis use?

Trust & Context

Key Stat:
Complete recovery despite multiple complicating factors
Evidence Grade:
Preliminary: single case report with no controlled comparison.
Study Age:
Published in 2022.
Original Title:
Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery.
Published In:
Cureus, 14(4), e23744 (2022)
Database ID:
RTHC-04219

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

What made this case diagnostically challenging?

The patient had cannabis use disorder, excessive vaping, prior COVID-19 illness, a pineal cyst, and extreme blood pressure elevation, any of which could potentially contribute to psychotic symptoms.

Does cannabis cause schizophrenia?

Cannabis use disorder with genetic loading increases the risk of progression to schizophrenia, but this case shows that severe psychosis can occur and fully resolve without progressing to a chronic condition.

What treatment worked?

The patient recovered completely on a first-generation antipsychotic (likely haloperidol) and a mood stabilizer.

Read More on RethinkTHC

Cite This Study

RTHC-04219·https://rethinkthc.com/research/RTHC-04219

APA

Siembida, Jagoda; Mohammed, Saaduddin; Chishty, Mariam; Leontieva, Luba. (2022). Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery.. Cureus, 14(4), e23744. https://doi.org/10.7759/cureus.23744

MLA

Siembida, Jagoda, et al. "Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery.." Cureus, 2022. https://doi.org/10.7759/cureus.23744

RethinkTHC

RethinkTHC Research Database. "Diagnostic Difficulties and Treatment Challenges of a Young ..." RTHC-04219. Retrieved from https://rethinkthc.com/research/siembida-2022-diagnostic-difficulties-and-treatment

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.